The Latest Breaking News from AstraZeneca

Several drug pricing experts say without key details, it’s hard to call the individual pharma deals a win for the Trump administration.

On the FTSE 100, gold miners Fresnillo and Endeavour Mining leapt 9.1% and 11% respectively.

AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration

TrumpRx.gov, a website where Americans can buy pharmaceutical drugs under President Donald Trump’s new drug pricing plan, is set to begin operation in 2026

UK ministers preparing to raise payments to end standoff with pharma industry, cited as reason for firms axing British investments

Algen Biotechnologies, a privately held biotech company specializing in advanced CRISPR gene modulation and AI-driven drug discovery, has announced a multi-target partnership with AstraZeneca Plc (NASDAQ:AZN) to accelerate the discovery of novel therapeutic targets in immunology.

AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo on Monday released high-level results from the TROPION-Breast02 Phase 3 trial.

Drug companies AstraZeneca, Hikma Pharmaceuticals and GSK were all big risers.

The UK’s science minister, Sir Patrick Vallance, has sounded the alarm over the country’s declining investment in medicines. He warned that the NHS risks losing out on important treatments and the country could lose its place at the cutting edge of medical research if spending does not recover. It comes…